Chemical Structure (Iclusig 01)
Iclusig Tablet, Film Coated
Product Images NDC 63020-533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Iclusig (NDC 63020-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (15 mg Tablet Bottle Label)
This is a medication with the name Iclusig, which comes in the form of tablets with 15mg of ponatinib. The tablet container has a label indicating the drug's name, dosage, storage recommendations, and prescription only usage. The drug is distributed by Takeda Pharmaceuticals in the USA and made in Canada. Anyone using the medications should keep it away from children, and dosage instructions should be read from accompanying documents.*
Principal Display Panel (45 mg Tablet Bottle Label)
Principal Display Panel (30 mg Tablet Bottle Label)
FPO is a pharmaceutical product with NDC 63020-533-30 comprising of Ponatinib tablets that contains 30 mg Ponatinib equivalent to 32.05 mg Ponatinib HCI. It is recommended to store this product at 20° to 25°C and keep away from children. Dosage and usage should be in accordance with the prescribed medication guide, and the product is distributed by Takeda Pharmaceuticals America, Inc. It contains 30 tablets for Rx only.*
Principal Display Panel (10 mg Tablet Bottle Label)
Store the IcLusic tablets containing 10mg ponatinib at a temperature between 20° to 25°C (68° to 77°F). The temperature can be slightly increased to 15° to 30°C (59° to 86°F) for excursions. The recommended dosage and use are available in the accompanying prescribing information. It is advisable to keep the tablets away from children. The product NDC code is 63020-536-30. The tablets contain 10.68 mg ponatinib HCI. A medication guide should be dispensed along with the 30 tablets. Rx use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
